New Approaches in Radiation Therapy

  • T. J. Kinsella
Part of the UICC International Union Against Cancer book series (UICCI)


According to recent statistics from the American Cancer Society, over 850 000 cases of invasive cancers are diagnosed yearly in the United States. Approximately 70% of these patients will present with locoregional disease potentially amenable to curative treatment using surgery, radiation therapy, or combined modality therapy. However, in spite of current treatment strategies, up to 30% of these patients will develop recurrent local disease which, in the majority, will lead ultimately to death. In addition, acute and late radiation damage to normal tissues can occur following high-dose external beam therapy used in definitive radiation therapy or as adjunctive therapy in combination with surgery and/or chemotherapy. We now realize that the radiation tolerance of some normal tissues can be modified in combined modality therapy due to additive or synergistic effects of surgery and, particularly, chemotherapy with radiation therapy.


Total Body Irradiation Hypoxic Cell Ataxia Telangiectasia Radiation Response Combine Modality Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barranco SC, Romsdahl MM, Humphrey RM (1971) The radiation response of human malignant melanoma cells grown in vitro. Cancer Res 31: 830–833PubMedGoogle Scholar
  2. 2.
    Weichselbaum RR, Epstein J, Little JB, Kornblith PL (1976) In vitro cellular radiosensitivity of human malignant tumors. Eur J Cancer 12: 47–51PubMedGoogle Scholar
  3. 3.
    Smith IE, Courtenay VC, Mills J, Peckham MJ (1978) In vitro radiation response of cells from four human tumors propagated in immune suppressed mice. Cancer Res 38: 390–392PubMedGoogle Scholar
  4. 4.
    Arlett CF, Harcourt SA (1980) Survey of radiosensitivity in a variety of human cell strains. Cancer Res 40: 926–932PubMedGoogle Scholar
  5. 5.
    Fertil B, Malaise EP (1981) Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys 1: 621–629Google Scholar
  6. 6.
    Weichselbaum RR, Malcolm AW, Little JB (1982) Fraction size and the repair of potentially lethal radiation damage in a human melanoma cell line. Radiology 1425: 225–227Google Scholar
  7. 7.
    Leith JT, Dexter DL, de Wyngaert JK, Zeman EM, Chu MY, Calabresi P, Glicksman AS (1982) Differential responses to X-irradiation of subpopulations of two heterogeneous human carcinomas in vitro. Cancer Res 42: 2556–2561PubMedGoogle Scholar
  8. 3.
    Carney DN, Mitchell JB, Kinsella TJ (1983) In vitro radiation and chemotherapy sensitivity of established cell lines of human small-cell lung cancer and its large-cell morphological variants. Cancer Res 43: 2806–2811.PubMedGoogle Scholar
  9. 9.
    Kinsella TJ, Mitchell JB, McPherson S, Miser J, Triche T, Glatstein E (1984) In vitro radiation studies on Ewing’s sarcoma cell lines and human bone marrow: application to the clinical use of total body irradiation (TBI). Int J Radiat Oncol Biol Phys 10: 1005–1011PubMedGoogle Scholar
  10. 10.
    Mitchell JB, Morstyn G, Russo A, Carney DN (1985) The in vitro radiobiology of human lung cancer. Cancer Treat Symp 2: 3–11Google Scholar
  11. 11.
    Withers HR (1975) The four R’s of radiotherapy. Adv Radiat Biol 5: 241–271Google Scholar
  12. 12.
    Hall EJ (1978) Radiobiology for the radiologist. Harper and Row, Hagerstown, MD, pp 136–139Google Scholar
  13. 13.
    Little JB (1969) Repair of sublethal and potential lethal radiation damage in plateau phase cultures of human cells. Nature 224: 804–806PubMedGoogle Scholar
  14. 14.
    Little JB, Hahn GM, Frindel E, Tubiana M (1973) Repair of potentially lethal radiation damage in vitro and in vivo. Radiology 106: 689–694PubMedGoogle Scholar
  15. 15.
    Weichselbaum RR, Little JB (1983) X-ray sensitivity and repair in human tumor cells. In Steel GG, Adams GE, Peckham MJ (eds) The biological basis of radiotherapy. Elsevier, Amsterdam, pp 113–121Google Scholar
  16. 16.
    Weischselbaum RR, Little JB (1982) The differential response of human tumours to fractionated radiation may be due to a postirradiation repair process. Br J Cancer 46: 532–537Google Scholar
  17. 17.
    Elkind MM (1979) DNA repair and cell repair: are they related? Int J Radiat Oncol Biol Phys 5: 1089–1094PubMedGoogle Scholar
  18. 18.
    Elkind MM (1980) Cells, targets and molecules in radiation biology: the Ernst W. Bertmer memorial award lecture. In: Meym R, Withers HR (eds) Radiation biology in cancer research. Raven, New York, pp. 71–93Google Scholar
  19. 19.
    Taylor AMR, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S, Bridges BA (1975) Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 258: 427–429PubMedGoogle Scholar
  20. 18.
    Cox R (1982) A cellular description of the repair defect in ataxia telangiectasia. In: Lehman A (ed) Ataxia telangiectasia. Wiley, Bristol, pp 141–153Google Scholar
  21. 21.
    Wilson RE, Antman KH, Brodsky G, Greenberger JS (1984) Tumor-cell heterogeneity in soft tissue sarcomas as defined by chemoradiotherapy. Cancer 53: 1420–1425PubMedGoogle Scholar
  22. 22.
    Goldie JH, Coldman AJ, Gudauskas GA (1982) Rationale for the use of alternating non-crossresistant chemotherapy. Cancer Treat Rep 66: 439–449PubMedGoogle Scholar
  23. 23.
    Terasima R, Tolmach LJ (1963) X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells. Science 140: 490–492PubMedGoogle Scholar
  24. 24.
    Mitchell JB, Bedford JS, Bailey SM (1979) Dose-rate effects in mammaliam cells in culture. III. Comparison of cell killing and cell proliferation during continuous irradiation for six different cell lines. Radiat Res 79: 537–551PubMedGoogle Scholar
  25. 25.
    Kallman RF, Combs CA, Franko AJ (1980) Evidence for the recruitment of non-cycling clonogenic tumor cells. In: Meyn R, Withers HR (eds) Radiation biology in cancer research. Raven, New York, pp 394–414Google Scholar
  26. 26.
    Denekamp J, Fowler JF (1977) Cell proliferation kinetics and radiation therapy. In Becker FF (ed) Cancer: a comprehensive treatise, vol 6. Plenum, New York, pp 101–137Google Scholar
  27. 27.
    Brownell GI, Budinger TF, Lauterbur PC (1982) Positron tomography and nuclear magnetic resonance imaging. Science 215: 619–626PubMedGoogle Scholar
  28. 28.
    Morstyn G, Hsu SM, Kinsella T, Gratzner H, Russo A, Mitchell JG (1983) Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody. J Clin Invest 72: 1844–1850PubMedGoogle Scholar
  29. 29.
    Thomlinson RH, Gray LH (1955) The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer 9: 539–549PubMedGoogle Scholar
  30. 30.
    Brown JM (1979) Evidence for acutely hypoxic cells in mouse tumors and a possible mechanism of reoxygenation. Br J Radiol 52: 650–656PubMedGoogle Scholar
  31. 31.
    Dische S (1979) Hyperbaric oxygen: the Medical Research Council trials and their clinical significance. Br J Radiol 51: 888–894Google Scholar
  32. 32.
    Urtasun RC, Band P, Chapman JD, Feldstein KL, Mielke B, Fryer C (1976) Radiation and high dose metronidazole (Flagyl) in supratentorial glioblastomas. N Engl J Med 293: 1364–1369Google Scholar
  33. 33.
    Urtasun R, Feldstein ML, Partington JL, Tanasichuk H, Miller JDR, Russell DB, Agboola A, Mielka B (1984) Radiation and nitroimidazoles and supratentorial high-grade gliomas: a second clinical trial. Br J Cancer 46: 101–108Google Scholar
  34. 34.
    Adams GE, Flockhart IR, Smithen CE, Stratford IJ, Wardman P, Watts ME (1976) Electronaffinic sensitization. VIII: a correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res 67: 9–20PubMedGoogle Scholar
  35. 35.
    Fowler JF, Denekamp J (1979) A review of hypoxic cell radiosensitization in experimental tumors. Pharmacol Ther 7: 413–444PubMedGoogle Scholar
  36. 36.
    Phillips TL, Wasserman TD (1984) Promise of radiosensitizers and radioprotectors in the treatment of human cancer. Cancer Treat Rep 68: 291–201PubMedGoogle Scholar
  37. 37.
    Urtasun RC, Tanasichuk H, Fulton D (1982) High dose misonidazole with dexamethasone rescue: a possible approach to circumvent neurotoxicity. Int J Radiat Oncol Biol Phys 8: 365–369PubMedGoogle Scholar
  38. 38.
    Eifel PJ, Brown DM, Lee WW, Brown JM (1983) Misonidazole neurotoxicity in mice decreased by administration with pyridoxine. Int J Radiat Oncol Biol Phys 9: 1513–1519PubMedGoogle Scholar
  39. 39.
    Brown JM (1984) Clinical trials of radiosensitizers: what should we expect? Int J Radiat Oncol Biol Phys 10: 425–429PubMedGoogle Scholar
  40. 40.
    Coleman CN (1985) Hypoxic cell radiosensitizers: expectations and progress in drug development. Int J Radiat Oncol Biol Phys 11: 323–329PubMedGoogle Scholar
  41. 41.
    Roberts JT, Bleehen NM, Workman P, Walton MI (1984) A phase I study of the hypoxic cell radiosensitizer RO-03–9877 in man. Int J Radiat Oncol Biol Phys 10: 1755–1758PubMedGoogle Scholar
  42. 42.
    Djordjevic B, Szybalski W (1960) Genetics of human cell lines. III. Incorporation of 5-bromo and 5-iododeoxyuridine into the deoxyribonucleic acid of human cells and its effect on radiation sensitivity. J Exp Med 112: 509–351PubMedGoogle Scholar
  43. 43.
    Kaplan HS, Smith KC, Tomlin PA (1962) Effect of halogenated pyrimidines on radiosensitivity of E. Coli. Radiat Res 16: 98–113Google Scholar
  44. 44.
    Hoshino T, Sano K (1969) Radiosensitization of malignant brain tumors with bromouridine (thymidine analog). Acta Radiol Ther Phys Biol 8: 15–26PubMedGoogle Scholar
  45. 45.
    Bagshaw MA, Doggett RLS, Smith KC, Kaplan HS, Nelsen TS (1967) Intra-arterial 5bromodeoxyuridine and X-ray therapy. Radiology 99: 886–894Google Scholar
  46. 46.
    Kinsella TJ, Mitchell JB, Russo A, Morstyn G, Glatstein E (1984) The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status and future prospects. Int J Radiat Oncol Biol Phys 10: 1399–1406PubMedGoogle Scholar
  47. 47.
    Russo A, Gianni L, Kinsella TJ, Klecker RW, Jenkins J, Rowland J, Glatstein E, Mitchell JB, Collins J, Myers CE (1984) A pharmacologic evaluation of intravenous delivery of BUdR to patients with brain tumors. Cancer Res 44: 1702–1705PubMedGoogle Scholar
  48. 48.
    Klecker RW, Jenkins J, Kinsella TJ, Fine R, Strong JM, Collins JM (1985) Clinical pharmacology of 5-iodo-2’deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation. Clin Pharmacol TherGoogle Scholar
  49. 49.
    Mitchell JB, Kinsella TJ, Russo A, McPherson S, Rowland J, Kornblith P, Glatstein E (1983) Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR). Int J Radiat Oncol Biol Phys 9: 457–463PubMedGoogle Scholar
  50. 50.
    Kinsella TJ, Mitchell JB, Russo A, Morstyn G, Hsu SM, Rowland J, Glatstein E (1984) Continuous intravenous infusion of bromodeoxyuridine (BUdR) as a clinical radiosensitizer. J Clin Oncol 2: 1144–1150PubMedGoogle Scholar
  51. 51.
    Kinsella TJ, Russo A, Mitchell JB, Rowland J, Jenkins J, Schwade J, Myers CE, Collins J, Speyer P, Kornblith P, Smith B, Kufta C, Glatstein E (1984) A phase I study of intermittent intravenous BUdR with conventional irradiation. Int J Radiat Oncol Biol Phys 10: 69–76PubMedGoogle Scholar
  52. 52.
    Kinsella TJ, Russo A, Mitchell JB, Collins J, Klecker R, Rowland J, Jenkins J, Glatstein E (1985) Phase I study of intravenous infusions of iododeoxyuridine (IUdR) as a clinical radiosensitizer. Int J Radiat Oncol Biol Phys 11: 1579–1585PubMedGoogle Scholar
  53. 53.
    Bump EA, Yu NY, Brown JM (1982) Radiosensitization of hypoxic tumor cells by depletion of intracellular glutathione. Science 217: 544–545PubMedGoogle Scholar
  54. 54.
    Harris JW (1983) Cellular thiols in radiation and drug response. In: Nygaard OF, Simic M (eds) Radioprotectors and anticarcinogens. Academic, New York, pp. 255–274Google Scholar
  55. 55.
    Mitchell JB, Russo A, Biaglow JE (1983) Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect on the oxygen enhancement ratio. Radiat Res 96: 422–428PubMedGoogle Scholar
  56. 56.
    Green JA, Vistica DC, Young RC, Hamilton TC, Rogan AM, Ozols RF (1984) Melphalan resistance in human ovarian cancer: characterization of drug resistant cell lines and potentiation of melphalan cytotoxicity by glutathione depletion. Cancer Res 44: 5427–5431PubMedGoogle Scholar
  57. 57.
    Louie KG, Behrens BC, Kinsella TJ, Hamilton TC, Grotzinger KR, McKoy WM, Winker MA, Young RC, Ozols RF (1985) Radiation survival parameters of antineoplastic drug-sensitive and resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res 45: 211–2115Google Scholar
  58. 58.
    Nakatsugawa S, Sugahara T, Kumar A (1982) Purine nucleoside analogues inhibit the repair of radiation-induced potentially lethal damage in mammalian cells in culture. Int J Radiat Biol 41: 343–346Google Scholar
  59. 59.
    Nakatsugawa S, Kumar A, Ono K (1982) Increased tumor curability by radiotherapy combined with PLDR inhibiters in murine cancer. In: Prospective methods of radiation therapy in developing countries, IAEA-TECDOR 2666International Atomic Energy Agency, Vienna, pp 77–86Google Scholar
  60. 59.
    Tanaka Y, Sugahara T (1979) Clinical experience of chemical radiation research protection in tumor radiotherapy in Japan. In: Brady L (ed) Radiation sensitizers. Masson, New York, pp 421–425Google Scholar
  61. 61.
    Blumberg A, Nelson D, Gramrowski M (1982) Clinical trials of WR-2721 with radiation therapy. Int J. Radiat Oncol Biol Phys 8: 561–564PubMedGoogle Scholar
  62. 62.
    Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J. Radiat Oncol Biol Phys 5: 85–91PubMedGoogle Scholar
  63. 63.
    Steel GG, Hill RP, Peckham MJ (1978) Combined radiotherapy-chemotherapy of Lewis lung carcinoma. Int J. Radiat Oncol Biol Phys 4: 49–52PubMedGoogle Scholar
  64. 64.
    Looney WB, Ritenhour ER, Hopkins HA (1981) Solid tumor models for the assessment of different treatment modalities. XVI. Sequential combined modality therapy. Cancer 47: 860–869PubMedGoogle Scholar
  65. 65.
    Berry RJ (1982) Interaction of drugs and radiation—promise or pitfall? Clin Radiol 33: 121–129PubMedGoogle Scholar
  66. 67.
    Barranco SC, May JT, Boerwinkle W (1982) Enhanced cell killing through the use of cell kinetics directed treatment schedules for two-drug combinations in vitro. Cancer Res 42: 2894–2898PubMedGoogle Scholar
  67. 67.
    Evanochko WT, No TC, Lilly MB, Lawson AJ, Corbett TH, Durant JR, Glickson JD (1983) In vivo 31P, NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, X-radiation and hyperthermia. Proc Natl Acad Sci USA 80: 334–338PubMedGoogle Scholar
  68. 68.
    D’Angio GJ, Evans A, Breslow N (1981) The treatment of Wilms’ tumor: results of the second national Wilms’ tumor study. Cancer 47: 2302–2311PubMedGoogle Scholar
  69. 69.
    Kinsella TJ, Glaubiger D, Deisseroth A, Makuch R, Waller B, Pizzo P, Glatstein E (1983) Intensive combined modality therapy including low dose TBI in high-risk Ewings’s sarcoma patients. Int J Radiat Oncol Biol Phys 9: 1955–1960PubMedGoogle Scholar
  70. 70.
    Al-Sarraf M, Jacobs J, Kinzie J, Marchial V, Velez-Garcia E, Glick J, Fu K (1983) Combined modality therapy utilizing single high intermittent dose of cis-platinum and radiation in patients with advanced head and neck cancer. Proc Am Soc Clin Oncol 2: 159Google Scholar
  71. 71.
    Cummings BJ, Rider WD, Harwood AR, Keane TJ, Thomas GM, Erlichman C, Fine S (1982) Combined radical radiation therapy and chemotherapy for primary squamous cell carcinoma of the anal canal. Cancer Treat Rep 66: 48–492Google Scholar
  72. 72.
    Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmon C, Fisher E (1985) Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl Med 312: 665–673Google Scholar
  73. 73.
    Rosenberg SA, Tepper J, Glatstein E (1982) The treatment of soft-tissue sarcomas of the extremities: prospective randomized trial of (1) limb-sparing surgery plus radiation therapy compared to amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196: 305–315PubMedGoogle Scholar
  74. 74.
    Kinsella TJ, Bloomer WD (1980) Bowel tolerance to radiation therapy. Surg Gynecol Obstet 151: 273–284PubMedGoogle Scholar
  75. 75.
    Abe M, Takahashi M (1981) Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys 7: 863–868PubMedGoogle Scholar
  76. 76.
    Sindelar WF, Kinsella TJ, Tepper J, Travis EL, Rosenberg SA, Glatstein E (1983) Experimental and clinical studies with intraoperative radiotherapy. Surg Gynecol Obstet 157: 205–219PubMedGoogle Scholar
  77. 77.
    Gunderson LL, Tepper JE, Biggs PJ, Goldson A, Martin JK, McCullough EC, Rich TA, Shipley WU, Sindelar WF, Wood WC (1983) Intraoperative ± external beam irradiation. In: Hickey RC (ed) Current problems in cancer. Year Book Medical Publishers, Chicago; pp 42–60Google Scholar
  78. 78.
    Kinsella TJ, Sindelar WF (1985) Intraoperative radiation therapy. In: De Vita VT, Hellman S, Rosenbery SA (eds) Principles and practice of oncology. Lippincott, Philadelphia; pp 2293–2304Google Scholar
  79. 79.
    Fuks Z, Strober S, Bobrove AM, Kaplan HS (1976) Long-term effects of radiation on T and B lymphocytes in peripheral blood of patients with Hodgkin’s disease. J Clin Invest 58: 803–814PubMedGoogle Scholar
  80. 80.
    Engleman EG, Benike CJ, Hoppe RT, Kaplan HS (1980) Autologous mixed lymphocyte reaction in patients with Hodgkin’s disease: evidence for a T-cell defect. J Clin Invest 66: 149–158PubMedGoogle Scholar
  81. 81.
    Schurman DJ, Hirshman HP, Strober S (1981) Total lymphoid and local joint irradiation in the treatment of adjuvant arthritis. Arthritis Rheum 24: 38–44.PubMedGoogle Scholar
  82. 82.
    Trentham DE, Belli JA, Anderson RJ (1981) Clinical and immunological effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med 305: 976–982PubMedGoogle Scholar
  83. 83.
    Najarian JS, Ferguson RM, Sutherland DER (1982) Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg 196: 442–452PubMedGoogle Scholar
  84. 84.
    Storb R, Thomas ED, Weiden PL (1978) One hundred and ten patients with aplastic anemia treated by marrow transplantation in Seattle. Transplant Proc 10: 135–140PubMedGoogle Scholar
  85. 85.
    Thomas ED, Buckner CD, Clift RA (1979) Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301: 597–599PubMedGoogle Scholar
  86. 86.
    Glode LM, Robinson WA, Hartmann DW, Klein JJ, Thomas MR, Morton N (1982) Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung. Cancer Res 42: 4270–4275PubMedGoogle Scholar
  87. 87.
    Coleman CN, Williams CJ, Flint A (1977) Hematologic neoplasia in patients treated for Hodgkin’s disease. N Engl J Med 297: 1249–1252PubMedGoogle Scholar
  88. 88.
    Tester WJ, Kinsella TJ, Waller B, Makuch RW, Kelley PA, Glatstein E, De Vita VT (1984) Second malignant neoplasms complicating Hodgkin’s disease: the National Cancer Institute experience J Clin Oncol 2: 762–769PubMedGoogle Scholar
  89. 89.
    Slavin S, Reitz B, Bieber CP (1978) Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. J Exp Med 147: 700–707PubMedGoogle Scholar
  90. 90.
    Kotzin BL, Strober S (1979) Reversal of MZB/NZW disease with total lymphoid irradiation. J Exp Med 150: 371–378PubMedGoogle Scholar
  91. 91.
    Koretz SH, Gottlieb MS, Strober S (1981) Organ transplantation in mongrel dogs using total lymphoid irradiation. Transplant Proc 13: 443–445PubMedGoogle Scholar
  92. 92.
    Thomas ED, Clift RA, Hersman J (1982) Marrow transplantation for acute non-lymphoblastic leukemia in first remission using fractionated or single dose irradiation. Int J Radiat Oncol Biol Phys 8: 817–821PubMedGoogle Scholar
  93. 93.
    Shank B, Simpson L (1982) The role of total body irradiation in bone marrow transplantation for leukemia. Bull NY Acad Med 58: 763–777Google Scholar
  94. 94.
    Reinhard EH (1975) Polycythemia. In: Beeson PB, McDermott W (eds) Textbook of medicine. Saunders, Philadelphia, pp 40–58Google Scholar
  95. 95.
    Leichner PK, Rosenshein NB, Leibel SA (1980) Distribution and tissue dose of intraperitoneally administered radioactive chromic phosphate in New Zealand white rabbits. Radiology 134: 729–734PubMedGoogle Scholar
  96. 96.
    Ariel IM, Padula G (1978) Treatment of metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radiotherapy isotopes. Prog Clin Cancer 7: 247–263PubMedGoogle Scholar
  97. 97.
    Goldenburg DM, Decand F, Kim E (1978) Use of radiolabelled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 298: 1384–1388Google Scholar
  98. 98.
    Ballou B, Levine G, Hakala TR (1979) Tumor location detected with radioactively labelled monoclonal antibody and external scintigraphy. Science 206: 844–847PubMedGoogle Scholar
  99. 99.
    Ettinger DS, Order SE, Wharam MD (1982) Phase I—II study of isotopic immunoglobulin therapy for primary liver cancer. Cancer Treat Rep 66: 289–297PubMedGoogle Scholar
  100. 100.
    Order SE (1982) Monoclonal antibodies’ potential role in radiation therapy and oncology. Int J Radiat Oncol Biol Phys 8: 1193–1201PubMedGoogle Scholar
  101. 101.
    Parker RG (1985) Particle radiation therapy. Cancer 55: 2240–2245PubMedGoogle Scholar
  102. 102.
    Pistenma DA (1985) Particle beam radiation therapy In: De Vita VT, Hellman S, Rosenburg SA (eds) Principles and practice of oncology. Lippincott, Philadelphia, pp 2280–2292Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • T. J. Kinsella

There are no affiliations available

Personalised recommendations